The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship of phosphodiesterase type 5 inhibitor to biochemical recurrence after definitive therapy for prostate cancer.
 
Michael S. Leapman
No Relationships to Disclose
 
Janet E. Cowan
No Relationships to Disclose
 
Hao Gia Nguyen
No Relationships to Disclose
 
Sima P. Porten
No Relationships to Disclose
 
Matthew R. Cooperberg
Honoraria - Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; dendreon; Myriad Pharmaceuticals
Research Funding - GenomeDx; Genomic Health (Inst); Myriad Pharmaceuticals (Inst)
 
Peter Carroll
Honoraria - Genomic Health; Janssen; Takeda
Consulting or Advisory Role - Astellas Pharma (Inst); Genomic Health (Inst); Medivation (Inst)